F-group (family)

11.1.1.97 I-set

Ligands and drugs

2,946
Member domains
297
with ligand contacts (≤ 4 Å)
10.1% of members
281
with DrugDomain annotations
9.5% of members
213
with a DrugBank compound
7.2% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 11.1.1.97 belongs to X-group 11 Immunoglobulin-like beta-sandwich, which binds 8.0 ligand superclasses per 20 proteins, broader than 58% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00141NAGN-Acetylglucosamine86
DB12010—Fostamatinib11
DB08896——7
DB09079—Nintedanib6
DB09078—Lenvatinib5
DB12147—Erdafitinib5
DB15685——5
DB15822—Pralsetinib5
DB00114—Pyridoxal phosphate4
DB00898—Ethanol4
DB06589——4
DB11800—Tivozanib4
DB00321—Amitriptyline3
DB02379—Beta-D-Glucose3
DB03721—N-acetyl-alpha-neuraminic acid3
DB11886—Infigratinib3
DB14723——3
DB15102—Pemigatinib3
DB15149—Futibatinib3
DB04879——2

Most frequently bound compounds

PDB ligandNameDomains in contact
NAG2-acetamido-2-deoxy-beta-D-glucopyranose97
CLCHLORIDE ION32
NAmetalSODIUM ION13
CAmetalCALCIUM ION11
ZNmetalZINC ION9
CDmetalCADMIUM ION6
IODIODIDE ION5
GM1AMINOMETHYLAMIDE2
NImetalNICKEL (II) ION2
12PDODECAETHYLENE GLYCOL1
15PPOLYETHYLENE GLYCOL (N=34)1
A1H624-[3-[[(1~{S})-1-(3-bromophenyl)-3-[2-(2-morpholin-4-ylethoxy)ethylamino]-3-oxidanylidene-propyl]carbamoyl]-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]-5-cyano-thieno[2,3-b]pyridine-2-carboxylic acid1
B3P2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL1
BMEBETA-MERCAPTOETHANOL1
CSmetalCESIUM ION1
GLYGLYCINE1
MGmetalMAGNESIUM ION1
YYJ1,3,4,6-tetra-O-sulfo-beta-D-fructofuranose1